Cited by 35Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of α4β2 and α3β2 Nicotinic Acetylcholine Receptors

Briggs, Clark A., Gubbins, Earl J., Marks, Michael J., Putman, C. Brent, Thimmapaya, Rama, Meyer, Michael D., Surowy, Carol S.·2006·Molecular Pharmacology

Abstract

alpha4beta2 nicotinic acetylcholine receptors (nAChRs) are recognized as the principal nicotine binding site in brain. Recombinant alpha4beta2 nAChR demonstrate biphasic concentration-response relationships with low- and high-EC50 components. This study shows that untranslated regions (UTR) can influence expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChR. Oocytes injected with alpha4 and beta2 RNA lacking UTR expressed biphasic concentration-response relationships for acetylcholine with high-sensitivity EC50 values of 0.5 to 2.5 microM (14-24% of the population) and low-sensitivity EC50 values of 110 to 180 microM (76-86%). In contrast, message with UTR expressed exclusively the high-sensitivity alpha4beta2 nAChR subform with an acetylcholine EC50 value of 2.2 microM. Additional studies revealed pharmacological differences between high- and low-sensitivity alpha4beta2 subforms. Whereas the antagonists dihydro-beta-erythroidine (IC50 of 3-6 nM) and methyllycaconitine (IC50 of 40-135 nM) were not selective between high- and low-sensitivity alpha4beta2, chlorisondamine, mecamylamine, and d-tubocurarine were, respectively, 100-, 8-, and 5-fold selective for the alpha4beta2 subform with low sensitivity to acetylcholine. Conversely, agonists that selectively activated the high-sensitivity alpha4beta2 subform with respect to efficacy as well as potency were identified. Furthermore, two of these agonists were shown to activate mouse brain alpha4beta2 as well as the ferret high-sensitivity alpha4beta2 expressed in Xenopus laevis oocytes. With the use of UTR-containing RNA, exclusive expression of a novel high-sensitivity alpha3beta2 nAChR was also achieved. These studies 1) provide further evidence for the existence of multiple subforms of alpha4beta2 nAChR, 2) extend that to alpha3beta2 nAChR, 3) demonstrate UTR influence on beta2-containing nAChR properties, and 4) reveal compounds that interact with alpha4beta2 in a subform-selective manner.

Integrity signals

Registry

Crossref · 10.1124/mol.105.020198

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 55 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Briggs, C. A., Gubbins, E. J., Marks, M. J., Putman, C. B., Thimmapaya, R., Meyer, M. D., & Surowy, C. S.
Affiliations
Abbott (United States) (US)
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
2006-07
Volume
70
Issue
1
Pages
227-240
ISSN
0026-895X (ISSN-L)
OpenAlex
W2284817657
Cited by
33
References
55
Citations by year
2015: 1 · 2014: 1 · 2013: 3 · 2012: 3
FWCI
2.72
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
nicotinic acetylcholine receptors, alpha4beta2 nAChR, alpha3beta2 nAChR, untranslated regions, dihydro-beta-erythroidine, methyllycaconitine, mecamylamine, chlorisondamine, tubocurarine, nicotinic agonists, nicotinic antagonists
MeSH terms
Acetylcholine, Aconitine, Animals, Chlorisondamine, Dihydro-beta-Erythroidine, Dose-Response Relationship, Drug, Estradiol, Female, Ferrets, Membrane Potentials, Mice, Inbred C57BL, Nicotine, Oocytes, Receptors, Nicotinic, Tubocurarine, Xenopus laevis, Gene Expression, Nicotinic Agonists, Nicotinic Antagonists, Protein Isoforms, 5' Untranslated Regions, Protein Subunits, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review